Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)

CAPS Rating: 1 out of 5

The Company is a biopharmaceutical company that discovers, develops, and intends to commercialize pharmaceutical products for the treatment of serious medical conditions.

Recs

0
Player Avatar corky1872001 (< 20) Submitted: 6/19/2007 7:48:39 PM : Outperform Start Price: $19.07 REGN Score: +602.54

treatment for caps

Featured Broker Partners


Advertisement